当前位置:首页 - 行情中心 - 博雅生物(300294) - 财务分析

博雅生物

(300294)

  

流通市值:123.89亿  总市值:123.89亿
流通股本:5.04亿   总股本:5.04亿

博雅生物(300294)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润3.43亿元,每股收益0.68元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益767244.88万元,未分配利润285206.23万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产872711.09万元,负债105466.21万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入1,473,924,123.261,007,772,869.56535,876,732.91,734,904,402.71
营业总成本1,228,094,382.4806,442,005.67409,830,144.221,279,267,786.34
其他经营收益
营业利润342,345,308.49262,723,884.73162,436,766.94477,254,740.43
利润总额341,334,751.51263,486,107.21163,352,843.76477,713,553.09
净利润343,042,957.61225,409,614.24139,291,778.48396,528,491.41
每股收益
其他综合收益-3,039,859.77-3,337,574.7-370,420.392,363,203.42
综合收益总额340,003,097.84222,072,039.54138,921,358.09398,891,694.83
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计5,114,533,961.354,997,937,423.715,047,474,258.375,058,350,132.04
非流动资产:
非流动资产合计3,612,576,945.823,679,934,943.413,431,232,325.363,342,794,636.95
资产总计8,727,110,907.178,677,872,367.128,478,706,583.738,401,144,768.99
流动负债:
流动负债合计918,495,852.52897,877,703.48696,575,578.9750,375,923.41
非流动负债:
非流动负债合计136,166,290.87149,839,647.46155,446,872.02163,006,070.86
负债合计1,054,662,143.391,047,717,350.94852,022,450.92913,381,994.27
所有者权益(或股东权益):
归属于母公司股东权益合计7,670,755,764.467,628,474,485.537,626,264,685.057,487,150,950.41
股东权益合计7,672,448,763.787,630,155,016.187,626,684,132.817,487,762,774.72
负债和股东权益合计8,727,110,907.178,677,872,367.128,478,706,583.738,401,144,768.99
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计1,363,006,049.57901,172,454.7427,195,622.751,683,847,519.89
经营活动现金流出小计1,336,895,407.69894,226,085.38469,315,119.371,384,066,263
经营活动产生的现金流量净额26,110,641.886,946,369.32-42,119,496.62299,781,256.89
投资活动产生的现金流量:
投资活动现金流入小计4,859,083,102.042,263,830,406.251,450,170,646.416,858,693,703.62
投资活动现金流出小计5,222,844,043.062,481,267,931.042,119,475,659.297,506,227,480.39
投资活动产生的现金流量净额-363,760,941.02-217,437,524.79-669,305,012.88-647,533,776.77
筹资活动产生的现金流量:
筹资活动现金流入小计2,162,988.7--5,237,675.71
筹资活动现金流出小计201,272,412.8184,155,805.191,696,873.99308,711,818
筹资活动产生的现金流量净额-199,109,424.11-84,155,805.19-1,696,873.99-303,474,142.29
汇率变动对现金及现金等价物的影响-57,739.96-7,950.9210,387.36-
现金及现金等价物净增加额-536,817,463.21-294,654,911.58-713,110,996.13-651,226,662.17
期末现金及现金等价物余额761,753,926.761,003,916,478.39585,460,393.841,298,571,389.97
补充资料:
现金及现金等价物的净增加额--294,654,911.58--651,226,662.17
最新报告期:2025-09-17
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信建投刘若飞,贺菊颖0.901.091.242025-09-17
华安证券谭国超0.961.101.272025-09-12
兴业证券孙媛媛,黄翰漾0.941.151.332025-09-07
东海证券杜永宏0.891.091.322025-09-03
野村东方国际证券孔令岩1.061.201.342025-08-27
TOP↑